40
Views
1
CrossRef citations to date
0
Altmetric
Letter

Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms

, , , &
Pages 1079-1080 | Published online: 12 Jun 2014

Dear editor

It is currently believed that predisposition for schizophrenia stems from the combined effect of multiple common polymorphisms. Thus, no genetic variant is considered to be fully responsible for the disease.Citation1 For this reason, analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms (SNPs) could provide information about the genetic mechanisms that underlie susceptibility.

Therefore, we have evaluated 100 common SNPs that were previously identified in schizophrenic patients by Need et al.Citation1 In particular, we analyzed the percentage of exchange associated with these various polymorphisms, obtaining the following rates for minor alleles: T (39%), C (22%), A (21%), and G (18%) [χ2=14.4; df=3; P=0.0024]. Moreover, our investigation revealed the following data with regard to rates for major alleles: C (34%), G (26%), T (21%), and A (19%) [χ2=25.84; df=4; P<0.0001].

Subsequently, we compared these nucleotide exchange rates with the percentage of bases utilized in the codons of the genetic code, which correspond to the 20 standard amino acids upon translation.Citation2

Based on this comparison, we propose three main hypotheses. First of all, the approximate doubling in the percentage of T (39%) as a substitute base results from additional T/U exchanges that occur during DNA to RNA transcription (and vice versa). Secondly, the location of most of these SNPs within intergenic and intronic (92%) regions implies that they are contained within non-coding RNAs (ncRNAs).Citation3 Among other functions, these ncRNAs may participate in the control and/or regulation of RNA splicing (creating new splicing patterns) and DNA transcription (RNA-mediated, creating new transposition patterns). Finally, our codonic analysis led us to hypothesize that these SNPs primarily affect proline-containing protein isotypes (ie, C is the most often replaced nucleotide, and codons corresponding to the amino acid proline display the highest proportion of C).Citation2

Proline motifs are frequently found in several members of the postsynaptic density (PSD) interactome, as well as several neurological and immunological proteins, such as carrier, accessory, adapter, and binding synapse proteins. Indeed, various intracellular signaling pathways could be affected by alterations in proline composition, including the following examples:

  1. Opioid agonists mediate Toll-like receptor 4 (TLR4) signaling through the myeloid differentiation primary response gene-88 (MyD88)-dependent pathway, which employs a proline-rich Src homology-3 (SH3)-binding motif in order to efficiently couple lipopolysaccharide (LPS) engagement by TLR4 to Src family kinase (SFK) activation. In contrast, the MyD88-independent pathway requires Toll-interleukin-1 receptor domain-containing adaptor molecule-1 (TICAM-1), which also harbors a proline-rich region.Citation4

  2. Receptor “clustering” at the immune synapse in memory B cells is mediated by the postsynaptic density-95/disc large/zona occludens-1 (PDZ) domain of synapse-associated protein-97 (SAP97), which is a carrier protein that contains SH3 domains to mediate protein–protein interactions via proline-rich sequences (XPpXP).Citation5

Therefore, genetic alterations (ie, SNPs), which can be found within intronic and intergenic regions of the genome in schizophrenic patients, might exist within ncRNAs that are involved in genetic replication, transcription, and translation. These ncRNAs may also participate in DNA transposition (RNA-mediated) and/or splicing events, which could yield deleterious effects on proline-containing proteins.Citation6,Citation7

Disclosure

The authors report no conflicts of interest in this work.

References

  • NeedACGeDWealeMEA genome-wide investigation of SNPs and CNVs in schizophreniaPLoS Genet200952e100037319197363
  • WatsonJDBakerTABellSPGannALevineMOosickRMolecular Biology of the GeneSan Francisco, CAPearson PLC2008522
  • PerkinsDOJeffriesCSullivanPExpanding the ‘central dogma’: the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophreniaMol Psychiatry2005101697815381925
  • HutchinsonMRNorthcuttALHiranitaTOpioid activation of toll-like receptor 4 contributes to drug reinforcementJ Neurosci20123233111871120022895704
  • LiuW1ChenEZhaoXWThe scaffolding protein synapse-associated protein 97 is required for enhanced signaling through isotype-switched IgG memory B cell receptorsSci Signal20125235ra5422855505
  • BundoMToyoshimaMOkadaYIncreased l1 retrotransposition in the neuronal genome in schizophreniaNeuron201481230631324389010
  • KaalundSSNewburnENYeTContrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brainMol Psychiatry12102013 [Epub ahead of print]